U.S. Department of Health and Human Services (HHS)

Rule Changes

Driving enforcement effort through declarations, investigations, and proposed rules

Lurie Children's Hospital, which opened the Midwest's first pediatric gender identity clinic in 2013, announced it will no longer prescribe gender-affirming medications to new patients under 18. This came days after HHS General Counsel Mike Stuart referred the hospital for federal investigation.

Updated 7 days ago

Force in Play

Froze $185M in Minnesota child care funding

On January 5, 2026, Governor Tim Walz announced he would drop his bid for a third term. The reversal came just two days before a contentious January 7 House Oversight Committee hearing where Republican state lawmakers testified that Walz and Attorney General Keith Ellison ignored widespread fraud and silenced whistleblowers.

Updated May 21

Rule Changes

Provided scientific/medical recommendation and is tasked with expanded research models

Trump's executive order instructing DOJ to fast-track marijuana's move to Schedule III immediately triggered a familiar split. Public health and industry groups cheered the potential research and tax impacts, while House Republicans organized opposition, urging Trump to keep marijuana in Schedule I.

Updated May 15

Rule Changes

Provided scientific/medical evaluation and scheduling recommendation to DEA

4-CMC is one of those modern drug-market products built for speed: cheap, tweakable chemistry that can be sold as a "new" stimulant the moment the old one gets banned. On December 17, 2025, the U.S. finally snapped the trap shut—DEA's Schedule I controls for 4-CMC took effect nationwide.

Updated May 15

Rule Changes

Political driver of ACIP restructuring and vaccine-schedule review

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 8–3 on December 5, 2025 to end the recommendation that every U.S. newborn receive a hepatitis B shot within 24 hours of birth. The committee had been recently overhauled under HHS Secretary Robert F. Kennedy Jr.; acting CDC Director Jim O'Neill ratified the change on December 16, 2025.

Updated May 9

Rule Changes

Promoted leucovorin for autism; FDA approval did not match its claims

In September 2025, White House officials told parents of autistic children that a cheap, generic drug called leucovorin might improve their children's speech and behavior. Prescriptions surged 71% in the following months, pharmacies ran dry, and the Food and Drug Administration (FDA) allowed emergency imports from Canada and Spain. On March 10, 2026, the FDA approved leucovorin — but only for a genetic condition so rare that fewer than 50 cases have ever been identified worldwide, not for autism.

Updated Mar 10

Rule Changes

Led by Secretary Robert F. Kennedy Jr.

Jay Bhattacharya co-authored the Great Barrington Declaration in October 2020, publicly opposing the Centers for Disease Control and Prevention's pandemic response policies. Five years later, he now controls both the CDC and the National Institutes of Health—the two largest federal public health agencies—making him the most powerful health official in America outside the cabinet.

Updated Feb 18